Recurrent Non-small Cell Lung Cancer Terminated Phase 2 Trials for RG-4733 (DB11870)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

IndicationStatusPhase
DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01193868RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line ChemotherapyTreatment